55 which revealed that males have a higher risk of hyperuricemia. The higher likelihood of hyperuricemia in males than females may be due to the action of sex hormones, in that the female sex hormone estrogen helps in the excretion of uric acid and could have the ability to maintain blood uric acid levels.
56,57 Besides, the risk of exposure to environmental and dietary factors that aid the synthesis of purine is higher in males than females, which may also contribute to the production of more uric acid owing to regulatory activity of purine metabolism, which further results in the release of high levels of uric acid into the circulation.
Omega-3 Fish Oil: Enhance Fat Loss, Boost Performance and Prevent Muscle Loss
High-fat diets are typically associated with gains in body fat, essentially because of the higher caloric density of fat. However, studies have shown that diets rich in omega-3 fatty acids found in fish oil, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can actually reduce body fat.
1-3 Both of these fatty acids are polyunsaturated fatty acids that contain a carboxylic acid group attached to a rather long chain of covalently linked carbon atoms. As polyunsaturated fats, they also have several double bonds within their carbon chain, which significantly alters their chemical structure relative to other dietary fats such as saturated and monounsaturated fatty acids. The difference in chemical structure gives omega-3 fatty acids, like EPA and DHA, the unique capacity to reduce body fat while also decreasing inflammation – which together contribute to the many health be
Even before the pandemic, mood/relaxing supplements were a booming category that grew at a compound annual growth rate (CAGR) of 5.7% from 2014 to 2019, reaching 1.3 billion euros in 2019, according to proprietary Euromonitor data.
COVID-19 has been a far-reaching health crisis, as its negative impacts go beyond the physical health of those who contract the virus and affect the emotional well-being of many people. Concerns about mental well-being grew from 36% of global consumers in April 2020 to 43% in May 2020, according to FMCG Gurus.
It is thus no surprise that IQVIA (“the human data science company”) reported the calming/sleep/mood over-the-counter (OTC) category to grow 25% in European pharmacy retail sell-out figures in March and that proprietary Euromonitor data forecasts mood/relaxing supplements to be one of the top five fastest-growing categories globally in 2020.